Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Mark Bodenrader
Age : 48
Country of residence : Unknown
Linked companies : Cerevel Therapeutics Holdings, Inc.

Biography of Mark Bodenrader 
Presently, Mark Bodenrader is VP-Finance, Chief Financial & Accounting Officer at Cerevel Therapeutics Holdings, Inc.


Current positions of Mark Bodenrader 
Holdings of Mark Bodenrader 
Mark Bodenrader : Personal Network 
Most Read News 
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/27ELON MUSK : Musk sued by Twitter investors for stock 'manipulation' during takeover bid
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/20LUCA DE MEO : Renault boss Luca de Meo could return to Japan in June - source
RE
More news


© 2022 People and Ownership :   
Mark Bodenrader : Connections 


Latest news about Mark Bodenrader 
03/01TRANSCRIPT : Cerevel Therapeutics Holdings, Inc., Q4 2021 Earnings Call, Mar 01, 2022
CI
2021CEREVEL THERAPEUTICS : CFO Kathy Yi Steps Down; Mark Bodenrader Named Interim CFO
MT
2021Cerevel Therapeutics Holdings, Inc. Announces Executive Changes
CI
2020Cerevel Therapeutics, LLC completed the acquisition of ARYA Sciences Acquisition Corp II from Bain Capital, LP and others in a reverse merger transaction.
CI
2020Cerevel Therapeutics, LLC entered into a definitive business combination agreement to acquire ARYA Sciences Acquisition Corp II from Bain Capital, LP and others for $780 million in a reverse merger transaction.
CI
More news